Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 26

    1.

    Influenza virus resistance to neuraminidase inhibitors.

    Mendel DB, Sidwell RW.

    Drug Resist Updat. 1998;1(3):184-9.PMID: 17092804 [PubMed]Related articles

    2.

    Avian influenza. Wild birds only partly to blame in spreading H5N1.

    Normile D.

    Science. 2006 Jun 9;312(5779):1451. No abstract available. PMID: 16763116 [PubMed - indexed for MEDLINE]Related articles

    3.

    Strategies for mitigating an influenza pandemic.

    Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS.

    Nature. 2006 Jul 27;442(7101):448-52. Epub 2006 Apr 26.PMID: 16642006 [PubMed - indexed for MEDLINE]Related articles

    4.

    Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.

    Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG, Stevens RC.

    J Am Chem Soc. 1997 Jan 29;119(4):681-90.PMID: 16526129 [PubMed - indexed for MEDLINE]Related articles

    5.

    Oseltamivir resistance during treatment of influenza A (H5N1) infection.

    de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J.

    N Engl J Med. 2005 Dec 22;353(25):2667-72.PMID: 16371632 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The genesis of a pandemic influenza virus.

    Russell CJ, Webster RG.

    Cell. 2005 Nov 4;123(3):368-71.PMID: 16269328 [PubMed - indexed for MEDLINE]Related articles

    7.

    Avian flu: isolation of drug-resistant H5N1 virus.

    Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y.

    Nature. 2005 Oct 20;437(7062):1108. Erratum in: Nature. 2005 Dec 8;438(7069):754. PMID: 16228009 [PubMed - indexed for MEDLINE]Related articles

    9.

    Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom.

    Ashton D, Hilton M, Thomas KV.

    Sci Total Environ. 2004 Oct 15;333(1-3):167-84.PMID: 15364527 [PubMed - indexed for MEDLINE]Related articles

    10.

    Encoding microbial metabolic logic: predicting biodegradation.

    Hou BK, Ellis LB, Wackett LP.

    J Ind Microbiol Biotechnol. 2004 Jul;31(6):261-72. Epub 2004 Jul 10.PMID: 15248088 [PubMed - indexed for MEDLINE]Related articles

    11.

    Low Flows 2000: a national water resources assessment and decision support tool.

    Young AR, Grew R, Holmes MG.

    Water Sci Technol. 2003;48(10):119-26.PMID: 15137161 [PubMed - indexed for MEDLINE]Related articles

    12.

    Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.

    Hurt AC, Barr IG, Hartel G, Hampson AW.

    Antiviral Res. 2004 Apr;62(1):37-45.PMID: 15026200 [PubMed - indexed for MEDLINE]Related articles

    13.

    Screening analysis of human pharmaceutical compounds in U.S. surface waters.

    Anderson PD, D'Aco VJ, Shanahan P, Chapra SC, Buzby ME, Cunningham VL, Duplessie BM, Hayes EP, Mastrocco FJ, Parke NJ, Rader JC, Samuelian JH, Schwab BW.

    Environ Sci Technol. 2004 Feb 1;38(3):838-49.PMID: 14968872 [PubMed - indexed for MEDLINE]Related articles

    14.

    Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

    McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M.

    Antimicrob Agents Chemother. 2003 Jul;47(7):2264-72.PMID: 12821478 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The generation of spatial population distributions from census centroid data.

    Bracken I, Martin D.

    Environ Plan A. 1989 Apr;21(4):537-43.PMID: 12315638 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metabolism of the influenza neuraminidase inhibitor prodrug oseltamivir in the rat.

    Sweeny DJ, Lynch G, Bidgood AM, Lew W, Wang KY, Cundy KC.

    Drug Metab Dispos. 2000 Jul;28(7):737-41.PMID: 10859145 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A review of avian influenza in different bird species.

    Alexander DJ.

    Vet Microbiol. 2000 May 22;74(1-2):3-13. Review.PMID: 10799774 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

    He G, Massarella J, Ward P.

    Clin Pharmacokinet. 1999 Dec;37(6):471-84. Review.PMID: 10628898 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oseltamivir.

    Bardsley-Elliot A, Noble S.

    Drugs. 1999 Nov;58(5):851-60; discussion 861-2. Review.PMID: 10595865 [PubMed - indexed for MEDLINE]Related articles

    20.

    Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.

    Li W, Escarpe PA, Eisenberg EJ, Cundy KC, Sweet C, Jakeman KJ, Merson J, Lew W, Williams M, Zhang L, Kim CU, Bischofberger N, Chen MS, Mendel DB.

    Antimicrob Agents Chemother. 1998 Mar;42(3):647-53.PMID: 9517946 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data